Skip to main content
Bajaj Healthcare Limited logo

Bajaj Healthcare Limited — Investor Relations & Filings

Ticker · BAJAJHCARE ISIN · INE411U01027 LEI · 335800ZUHJGHF22IN320 BSE.NS Manufacturing
Open in API
Filings indexed 328 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS BAJAJHCARE

About Bajaj Healthcare Limited

http://www.bajajhealth.com

Bajaj Healthcare Limited specializes in the development, manufacturing, and supply of Active Pharmaceutical Ingredients (APIs), Intermediates, and Finished Dosage Forms (FDFs). The company maintains a diverse product portfolio encompassing amino acids, nutritional supplements, and therapeutic agents across segments such as anti-diabetic, anti-convulsant, and cardiovascular health. Notable products include Ascorbic Acid, Citrates, and various mineral salts catering to the pharmaceutical, food, and nutraceutical sectors. With a strong emphasis on research and development, the company focuses on process chemistry and cost-effective manufacturing techniques. Its operations are supported by multiple manufacturing units designed to meet international quality standards and regulatory compliance, serving a broad client base in domestic and international markets.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report
Regulatory Filings Classification · 90% confidence The document is titled “Annual Secretarial Compliance Report for the financial year ended March 31, 2026,” prepared and signed by the Practicing Company Secretary under SEBI (LODR) Regulation 24A. It is essentially an officer’s certification/attestation of regulatory compliance (secretarial compliance), not the actual annual financial report or governance code. Per the Certification Rule, such compliance certificates should be classified as a Regulatory Filing (RNS).
2026-05-30 English
Intimation for Newspaper Publication
Earnings Release Classification · 75% confidence The document is a SEBI Regulation 47 compliance notice for newspaper publication of audited quarterly/annual financial results, including a table of key financial figures. This is not a full interim report or annual report but rather the initial public announcement of the periodical results. Therefore, it fits the definition of an Earnings Release. FY 2026
2026-05-10 English
Copy of Newspaper Publication
Earnings Release Classification · 72% confidence The document is a formal compliance notice under SEBI regulations, including the audited financial results for the quarter and full year ended March 31, 2026, published in newspapers. It constitutes the initial public announcement of periodical financial results (key profit, loss, EPS, reserves, etc.) rather than a full annual or interim report or management commentary. Therefore, it aligns with an Earnings Release. FY 2026
2026-05-10 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed announcement of the outcome of a Board Meeting held on May 8, 2026, by Bajaj Healthcare Limited. It includes the approval of the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026, along with the Auditor's Report. The document contains comprehensive financial data such as income statements, balance sheets, notes on discontinued operations, segment information, and details on dividends and auditor appointments. The presence of full financial statements and detailed analysis for the fiscal year indicates this is a full annual financial report. The document is lengthy (15,000 characters) and contains actual financial data, not just an announcement or summary. Therefore, it fits the definition of an Annual Report (10-K equivalent). FY 2026
2026-05-09 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated May 8, 2026, announcing the audited financial results for the quarter and year ended March 31, 2026. It contains detailed financial highlights, revenue breakup, and management commentary on the results. The document is about quarterly and annual financial performance but is presented as a press release rather than a full comprehensive report. It includes key financial metrics and management discussion but does not contain full financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The document is longer than 5,000 characters and contains substantive financial data and analysis, which aligns with an Earnings Release (ER) rather than a simple announcement or regulatory filing. Therefore, the most appropriate classification is Earnings Release (ER). Q4 2026
2026-05-08 English
Statement of deviation(s) or variation(s) under Reg. 32
Capital/Financing Update Classification · 95% confidence The document is a formal statement addressed to stock exchanges regarding the use of proceeds raised through a preferential issue of equity shares and convertible warrants. It references Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of deviations or variations in the use of funds raised. The document includes detailed tables showing the original and utilized amounts, confirms no deviation or variation, and is signed by company officials including the CFO and Company Secretary. It is a compliance disclosure related to capital raising and fund utilization, not a full financial report or earnings release. This fits the category of Capital/Financing Update (CAP), as it updates on the use of funds raised through a capital market transaction.
2026-05-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.